Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04060251
Other study ID # 2018P000932
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 4, 2019
Est. completion date January 17, 2022

Study information

Verified date May 2023
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate how different pre-operative therapeutic approaches affect quad strength and patient satisfaction after total knee replacements. There are three treatments groups: standard physical therapy protocol, the use of CyMedica NMES garments, and a telemedical home therapy program.


Description:

Patients undergoing total knee replacement (TKR) at Brigham and Women's Faulkner Hospital and meet all eligibility criteria will be informed about the study and asked if they would like to participate. The research assistant (RA) will screen upcoming surgeries and call all qualifying patients to inform them of the study. Those who show interest will be offered the opportunity to discuss with both the RA and Principal Investigator (PI). Upon agreement, the patient's consent will be obtained and they will be randomly assigned to one of three treatment groups using a computer-generated randomization.


Recruitment information / eligibility

Status Terminated
Enrollment 21
Est. completion date January 17, 2022
Est. primary completion date January 17, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or older - Owns a device with internet connection - Can download the E-vive application for the contractile garment (has sufficiently up-to-date phone or tablet, or has family member with such a device). - Has a rudimentary understanding of Internet technology, especially e-mail - Has a flexion of 90 o and flexion contracture of 5 o at the point of discharge - Approved by a physical therapist to participate safely in the study at the time of discharge Exclusion Criteria: - Rheumatoid arthritis - History of epilepsy - Implanted and body-worn electronic medical device, including cardiac pacemakers, neural stimulators, insulin pumps, etc. - Poor understanding of the use of the brace/electrical stimulation - Lesions on the skin over the thigh - Uncontrolled diabetes - Uncontrolled hypertension - Bilateral TKA or UKA planned - If female, pregnant - Cannot use non-operated leg postoperatively to propel active motion splint, caused by neurological or muscular diseases such as complete or incomplete paralysis or other causes of weakness with an inability to bend or extend knee - Loss of sensation in operated or non-operated leg - Has below- or above-knee amputations of non-operative leg - Below- knee amputation of operated side - Chronic pain syndrome with inability to walk - Taking chronic narcotics and/or is taking more than 10mg codeine per day, or any Hydrocodone, or more than 200 mg of tramadol, or any other narcotics prescribed for moderate to severe pain - Involved in pain clinics for chronic pain, or pain that is not related to the knee - Has been diagnosed with knee disorder other than osteoarthritis, post-traumatic osteoarthritis, gout, pseudo gout, or any inability to walk due to disorders unrelated to the knee (e.g., hip disorders, spinal stenosis, paralysis, hemi-paralysis)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CyMedica e-viveā„¢ System; CY-1000
All the patients in Group 2 will be given the CyMedica Orthopedics e-vive system 3 weeks before the surgery. The patients will begin using the unit after their first pre-intervention measurements are taken. Patients will be instructed to apply the e-vive NMES Strength therapy twice a day, 5 days a week. The NMES Strength program is 20 minutes in length. Treatment intensity (adjustable from 1 to 100 in NMES programs) is required to be set at the highest tolerable limit for the patients. Stimulation from the garment will have the following parameters: frequency of 50 Hz; pulse duration of 5 ms; time on: 12.8 seconds; and time off: 10 seconds. The total contraction time in a 20-minute treatment will be 11 minutes. The waveform will be pulsed and asymmetrical.
Other:
iGetBetter telemedicine physical therapy
Group 1 patients will only use a Post-Op program from iGetBetter for the first 3 weeks after surgery. After those 3 weeks have elapsed, Group 1 patients will receive outpatient physical therapy in addition to iGetBetter, approximately twice per week for the next 6-8 weeks as all other groups.

Locations

Country Name City State
United States Brigham and Women's Faulkner Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Wolfgang Fitz, M.D. CyMedica Orthopedics, Inc

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sit-to-stand Time Change in sit-to-stand capabilities Preoperative (varies) and postoperative appointments (2 months after surgery)
Primary Quadriceps Strength Change in quadriceps strength in lbs of force, as measured by PT dynamometer Preoperative and postoperative appointments (2 months after surgery)
Primary 2 Minute Walking Time Change in distance walked in 2 minutes Preoperative and postoperative appointments (2 months after surgery)
Primary Walking Speed Change in walking speed Preoperative and postoperative appointments (2 months after surgery)
Primary Balancing Change in proprioception (balance) as measured by 30-second single limb stance PT test Preoperative and postoperative appointments (2 months after surgery)
Secondary Visual Analogue Scale (VAS) Pain Change in Visual Analog Scale for pain (1-10) 1 no pain 10 worse first postoperative months (from days post-op through 2-month post-operative appointment)
Secondary Visual Analogue Scale (VAS) Nausea Change in VAS nausea (Visual Analog Scale for nausea (1-10) 1 no nausea 10 worse nausea ) first postoperative months (from days post-op through 2-month post-operative appointment)
Secondary Visual Analogue Scale (VAS) Satisfaction Change in VAS satisfaction (Visual Analog Scale for satisfaction (1-10) 1 not satisfied, 10 totally unsatisfied) first postoperative months (from days post-op through 2-month post-operative appointment)
Secondary Readmission Rate major complication Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
Secondary Infection Rate superficial and deep infection Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
Secondary Cost Per Treatment Regimen (iGetBetter vs. CyMedica E-vive vs. Home PT) We will calculate the total cost of each treatment modality Completion of study (anticipate one year from start data 4/4/2019)
See also
  Status Clinical Trial Phase
Completed NCT03542981 - Interferential Current Therapy After Total Knee Arthroplasty N/A
Recruiting NCT04458480 - Effect of Fast Inpatient Rehabilitation After TKA
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Recruiting NCT05391828 - Persona MC vs PS RCT With ROSA N/A
Active, not recruiting NCT04850300 - Efficiency Assessment of the Methodology for the Follow-up of Patients With Knee Prostheses Phase 3
Completed NCT05635916 - Trial of Liposomal Bupivacaine for TKA Phase 4
Enrolling by invitation NCT05130216 - Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
Withdrawn NCT02495805 - Ultrasound-guided Continuous Proximal Adductor Canal vs Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty N/A
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Completed NCT01616836 - Optimizing Pain and Rehabilitation After Knee Arthroplasty Phase 3
Withdrawn NCT01511211 - Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic Phase 4
Not yet recruiting NCT00958945 - Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements N/A
Completed NCT00985920 - Topical Tranexamic Acid for Total Knee Arthroplasty Phase 4
Completed NCT00761956 - A Study to Compare the NexGen CR and CR-Flex Knee Implants N/A
Completed NCT03289247 - Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty N/A
Terminated NCT03316118 - US Guided GNB vs Saline Injection for TKA Phase 4
Recruiting NCT05962970 - Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty N/A
Completed NCT03317834 - Navio With Total Knee Arthroplasty
Enrolling by invitation NCT06188091 - Joint Movement to Increase Range of Motion in Knee Joint After Primary Total Knee Arthroplasty N/A